Back to search

United Kingdom· GB-APID-45486011000001108

Glycopyrronium bromide 2mg tablets

A glycopyrronium product containing glycopyrronium bromide, registered in United Kingdom by Sovereign Medical Ltd. The same ATC class is registered in 14 of our 19 countries.

ATC D11AA01

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedGlycopyrronium bromide 2mg tabletsATCD11AA01REGISTER NO.GB-APID-4548601100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Glycopyrronium is registered in 14 of 19 countries.

Countries holding a registration under ATC D11AA01 (glycopyrronium), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose

Glycopyrronium · ATC D11AA01

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Glycopyrronium bromide
Manufacturer
Sovereign Medical Ltd
Country
United Kingdom (GB)
ATC code
D11AA01
ATC class
Glycopyrronium
Defined daily dose
8.8 mg, T
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5021730035402

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

108 interactions on record for glycopyrronium.

Graded by severity as the source publishes them — 107 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Glycopyrronium · interactions on record

108 records

  • 107 moderate
  • 1 minor

Most severe, free to view

  • DicycloverineA03AA07moderate
  • PropanthelineA03AB05moderate
  • MepenzolateA03AB12moderate
  • TrospiumA03AB20moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glycopyrronium in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glycopyrronium products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Axhidrox, Glycopyrroniumbromid Accord
  • Belgium · Axhidroks, Robinul
  • Bulgaria · Axhidrox, Амидил Амихалер
  • Cyprus · Glycopyrronium Bromide Accord, Robinul
  • Czechia · Amidil Amihaler, Axhidrox
  • Germany · Axhidrox, Glycopyrronium Axiromed
  • Denmark · Axhidrox, Glycopirronium Medical Valley
  • Estonia · Axhidrox
  • Finland · Axhidrox, Glykopyrroniumbromidi Accord
  • France · Glycopyrronium Biogaran, Glycopyrronium Wolff
  • Greece · Axhidrox, Glycopyrronium Verisfield
  • Croatia · Axhidrox
  • Hungary · Axhidrox, Rybrila
  • Ireland · Axhidrox, Glycopyrronium Bromide Ethypharm
  • Iceland · Seebri Breezhaler, Sialanar
  • Italy · Axhidrox, Glicopirronio Bromuro Accord
  • Liechtenstein · Seebri Breezhaler, Sialanar
  • Lithuania · Akshidroz
  • Luxembourg · Axhidroks, Robinul
  • Latvia · Axhidrox
  • Malta · Glycopyrronium Morningside
  • Netherlands · Axhidrox, Dusmyla
  • Norway · Axhidrox, Glycopirronium Medical Valley
  • Poland · Amidil Amihaler, Axhidrox
  • Portugal · Glicopirrónio Axidrox
  • Romania · Axhidrox
  • Sweden · Axhidrox, Glycopirronium Medical Valley
  • Slovenia · Axhidrox
  • Slovakia · Axhidrox

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bf5a4e5d-ca04-44a1-9008-ede11a3d7dae
GET /v1/drugs/bf5a4e5d-ca04-44a1-9008-ede11a3d7dae?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "45486011000001108",
  "desc": "Glycopyrronium bromide 2mg tablets (Sovereign Medical Ltd)",
  "form": "Oral tablet",
  "vpid": "11490211000001100",
  "source": "dmd",
  "vtm_id": "13298001000001103",
  "strength": "2 mg",
  "substance": "Glycopyrronium bromide",
  "ingredient": "Glycopyrronium bromide",
  "supplier_code": "3307301000001107"
}

See everything about glycopyrronium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.